Chuck Royce's position in OptimizeRx is currently worth $14.7M. That's 0.14% of their equity portfolio (218th largest holding). The investor owns 4.39% of the outstanding OptimizeRx stock. The first OptimizeRx trade was made in Q2 2020. Since then Chuck Royce bought shares six more times and sold shares on five occasions. The stake costed the investor $4.4M, netting the investor a gain of 234% so far.